1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Recurrent Visual Pathway Glioma: new trials by email Literature Review of Recurrent Visual Pathway Glioma trials Research Report on Recurrent Visual Pathway Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Entinostat, Laboratory Biomarker Analysis, Pharmacological Study - Brain Stem Neoplasm, Pineal Region Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 21 | 2017-01-06 | 2023-10-17 |
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Biospecimen Collection, Selumetinib - Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 217 | 2010-07-07 | 2026-09-21 |
Astrocytoma (1) · Brain Stem Neoplasms (1) · Central Nervous System Neoplasms (1) · Lymphoma (1) · Neurofibromatosis 1 (1) · Pinealoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Nervous System Diseases (2) · Neuroectodermal Tumors (2) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Glioma (1) · Hemic and Lymphatic Diseases (1)
AZD 6244 (1) · Specimen Handling (1) · entinostat (1)
National Cancer Institute (NCI) (2)
United States (2)
Andrew Bukowinski (1) · Jason R Fangusaro (1)
U01CA081457 (1), UM1CA081457 (1), UM1CA097452 (1)